<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320472">
  <stage>Registered</stage>
  <submitdate>7/09/2009</submitdate>
  <approvaldate>7/09/2009</approvaldate>
  <actrnumber>ACTRN12609000777291</actrnumber>
  <trial_identification>
    <studytitle>The effect of robotic-assisted upper limb therapy on upper limb improvements following stroke</studytitle>
    <scientifictitle>The effect of robot assisted upper limb therapy compared to usual care on upper limb improvements following stroke</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Stroke</healthcondition>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Ischaemic</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Haemorrhagic</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>15 minutes of upper limb robotic therapy using the Bimanutrack as part of 45 minute treatment session with remainder standard treatment. Robotic therapy consists of 150-250 repetitions of passive and/or active-passive program on Bimanutrack robotic in both wrist flexion-extension, and pronation-supination positions. Intervention is provided 5 days per week for 4 weeks within usual 45 minute therapy session.</interventions>
    <comparator>Standard treatment 5 days per week for 4 weeks with 45 minute session duration per day. Standard Treatment - includes bilateral training, relaxation, visualisation, grasp/release activities, passive range of motion with therapist, resisted strength training (eg with weighted cuffs), massage, and use of upper limb in functional tasks.</comparator>
    <control>Active</control>
    <interventioncode>Rehabilitation</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Wolf Motor Function Test</outcome>
      <timepoint>At baseline, and immediately and 3 months after intervention ceases.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Fugl Meyer Assessment of Motor Function</outcome>
      <timepoint>At baseline, and immediately and 3 months after intervention ceases.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Active range of motion of wrist flexion and extension, and forearm supination and pronation - measured using a goniometer.</outcome>
      <timepoint>At baseline, and immediately and 3 months after intervention ceases.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Diagnosis of stroke
No premorbid neurological deficits
Sufficient receptive and expressive language and cognitive ability to understand the study and provide consent
Sufficient sitting balance to use the robotic
Motor power grade of 3 or less in wrist flexion/extension and /or elbow pronation/supination.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Upper limb contractures
Significant increased tone (Modified Ashworth Scale =4)
Active arthritis in finger, elbow or wrist joints
Shoulder-hand syndrome</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation is not concealed</concealment>
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>7/09/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Sharyn Chaplin</primarysponsorname>
    <primarysponsoraddress>Daws Rd, Daw Park, South Australia 5041</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Foundation Daw Park</fundingname>
      <fundingaddress>Daws Rd, Daw Park, South Australia 5041</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Karen Brown</sponsorname>
      <sponsoraddress>Daws Rd, Daw Park, South Australia 5041</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Stacey George</othercollaboratorname>
      <othercollaboratoraddress>Daws Rd, Daw Park, South Australia 5041</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of the study is to gain information on the effectiveness of the use of robotics as a type of treatment for the recovery of movement of the upper limb (arm) for clients following a stroke. It specifically investigates whether the use of this particular robotic (Bimanutrack) in therapy, results in improved arm function following a stroke.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Repatriation General Hospital (RGH) Research and Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate>15/09/2008</ethicapprovaldate>
      <hrec>31.08</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Sharyn Chaplin</name>
      <address>Repatriation General Hospital
Daws Rd, Daw Park, South Australia 5041</address>
      <phone>+ 61 8 8275 1710</phone>
      <fax />
      <email>Sharyn.Chaplin@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Sharyn Chaplin</name>
      <address>Repatriation General Hospital
Daws Rd, Daw Park, South Australia 5041</address>
      <phone>+61 8 8275 1710</phone>
      <fax />
      <email>Sharyn.Chaplin@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>